3
H index
1
i10 index
73
Citations
University of York | 3 H index 1 i10 index 73 Citations RESEARCH PRODUCTION: 4 Articles 4 Papers RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Marta O. Soares. | Is cited by: | Cites to: |
Journals with more than one article published | # docs |
---|---|
PharmacoEconomics | 3 |
Working Papers Series with more than one paper published | # docs |
---|---|
Working Papers / Centre for Health Economics, University of York | 4 |
Year | Title of citing document | |
---|---|---|
2021 | Latent Ornstein?Uhlenbeck models for Bayesian analysis of multivariate longitudinal categorical responses. (2021). Duyck, Joke ; Verbeke, Geert ; Lesaffre, Emmanuel ; Tran, Trung Dung. In: Biometrics. RePEc:bla:biomet:v:77:y:2021:i:2:p:689-701. Full description at Econpapers || Download paper | |
2021 | Paying for health gains. (2021). Chalkley, Martin ; Gravelle, Hugh ; Gutacker, Nils ; Gaughan, James ; Siciliani, Luigi. In: Working Papers. RePEc:chy:respap:183cherp. Full description at Econpapers || Download paper | |
2021 | Eliciting a monetary threshold for a year of sufficient capability to inform resource allocation decisions in public health and social care. (2021). Afentou, Nafsika ; Kinghorn, Philip. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003099. Full description at Econpapers || Download paper | |
2021 | . Full description at Econpapers || Download paper | |
2021 | How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13. (2021). Martin, Stephen ; Longo, Francesco ; Claxton, Karl ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00663-3. Full description at Econpapers || Download paper | |
2020 | Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy. (2020). Rodriguez-Sanchez, B ; Sinclair, A J ; Pea-Longobardo, L M. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:3:d:10.1007_s10198-019-01134-2. Full description at Econpapers || Download paper | |
2020 | Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach. (2020). Lomas, James ; Gu, Yuanyuan ; Wang, Haiyin ; Ochalek, Jessica ; Jin, Chunlin ; Cutler, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00954-y. Full description at Econpapers || Download paper | |
2020 | Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment. (2020). Carlson, Josh J ; Ramsey, Scott D ; Veenstra, David L ; Basu, Anirban ; Bennette, Caroline S ; Guzauskas, Gregory F ; Kim, David D. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00848-8. Full description at Econpapers || Download paper | |
2020 | How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effective. (2020). Brennan, Alan ; Stevens, John ; Kearns, Ben . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00853-x. Full description at Econpapers || Download paper | |
2020 | After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6. Full description at Econpapers || Download paper | |
2021 | Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2. Full description at Econpapers || Download paper | |
2021 | NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8. Full description at Econpapers || Download paper | |
2020 | Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study. (2020). Maredza, Mandy ; Khan, Iftekhar ; Petrou, Stavros ; Perkins, Gavin D ; Gates, Simon ; Couper, Keith ; Lamb, Sarah E ; Lall, Ranjit ; Mistry, Dipesh ; Dritsaki, Melina. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00210-1. Full description at Econpapers || Download 2020 | Economic Tendencies of the European and Latvian Medical Device Market. (2020). Nadezhda, Semjonova. In: Economics and Business. RePEc:vrs:ecobus:v:34:y:2020:i:1:p:297-310:n:20. Full description at Econpapers || Download paper |
2021 | Estimating optimal willingness to pay thresholds for cost?effectiveness analysis: A generalized method. (2021). Cinatl, Chris ; Phelps, Charles E. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:7:p:1697-1702. Full description at Econpapers || Download paper |
Year | Title | Type | Cited |
---|---|---|---|
2014 | Treatment comparisons for decision making: facing the problems of sparse and few data In: Journal of the Royal Statistical Society Series A. [Full Text][Citation analysis] | article | 3 |
2010 | Simulation or cohort models? Continuous time simulation and discretized Markov models to estimate cost-effectiveness In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
2011 | Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies In: Working Papers. [Full Text][Citation analysis] | paper | 2 |
2013 | Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers. [Full Text][Citation analysis] | paper | 55 |
2014 | Network Meta-Analysis of (Individual Patient) Time to Event Data Alongside (Aggregate) Count Data In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
2012 | Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis In: PharmacoEconomics. [Full Text][Citation analysis] | article | 6 |
2016 | The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
2017 | Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 30 2022. Contact: CitEc Team